Cecilia A. Larocca

Cecilia A. Larocca

Dermatology

450 Brookline Avenue
Boston, MA 02115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Primary Cutaneous Anaplastic Large Cell Lymphoma in a Patient With Li Fraumeni Syndrome.

Primary Cutaneous Anaplastic Large Cell Lymphoma in a Patient With Li Fraumeni Syndrome.

Journal: The American Journal of dermatopathology

Published: August 03, 2026

Real-World Experience With TRBC1 Immunohistochemistry Across Cutaneous T-Cell Lymphoma Subtypes:A Large Cohort Study.

Real-World Experience With TRBC1 Immunohistochemistry Across Cutaneous T-Cell Lymphoma Subtypes:A Large Cohort Study.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: May 16, 2026

The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid Neoplasms.

The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid Neoplasms.

Journal: The American journal of surgical pathology

Published: April 20, 2026

Cardiometabolic Associations of Dermatological Treatments. Part I: Systemic Therapies.

Cardiometabolic Associations of Dermatological Treatments. Part I: Systemic Therapies.

Journal: Journal of the American Academy of Dermatology

Published: April 15, 2026

Cardiometabolic Associations of Dermatological Treatments. Part II: Targeted and Biologic Therapies.

Cardiometabolic Associations of Dermatological Treatments. Part II: Targeted and Biologic Therapies.

Journal: Journal of the American Academy of Dermatology

Published: April 15, 2026

Qualitative assessment of the content validity of pruritus patient-reported outcome measures in mycosis fungoides and Sézary syndrome.

Qualitative assessment of the content validity of pruritus patient-reported outcome measures in mycosis fungoides and Sézary syndrome.

Journal: The British journal of dermatology

Published: April 08, 2026

Assessing content validity of the functional assessment of cancer therapy-cutaneous T-cell lymphoma (FACT-CTCL): a qualitative study.

Assessing content validity of the functional assessment of cancer therapy-cutaneous T-cell lymphoma (FACT-CTCL): a qualitative study.

Journal: Journal of patient-reported outcomes

Published: February 10, 2026

Protocol for a mixed-methods modified Delphi study for the development of a core domain set to assess the health-related quality of life of patients with mycosis fungoides and Sézary syndrome in clinical trials.

Protocol for a mixed-methods modified Delphi study for the development of a core domain set to assess the health-related quality of life of patients with mycosis fungoides and Sézary syndrome in clinical trials.

Journal: BMJ open

Published: February 06, 2026

Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting.

Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting.

Journal: Journal of drugs in dermatology : JDD

Published: December 02, 2025

Clinical presentation and survival outcomes of primary cutaneous T-cell lymphoma among disaggregated Asian American, Native Hawaiian, and Pacific Islander populations.

Clinical presentation and survival outcomes of primary cutaneous T-cell lymphoma among disaggregated Asian American, Native Hawaiian, and Pacific Islander populations.

Journal: Journal of the American Academy of Dermatology

Published: May 23, 2025

Increasing incidence of cutaneous T-cell lymphoma among children and young adults in the United States, 1997-2019: A national poplation-based study using the National Childhood Cancer Registry.

Increasing incidence of cutaneous T-cell lymphoma among children and young adults in the United States, 1997-2019: A national poplation-based study using the National Childhood Cancer Registry.

Journal: Journal of the American Academy of Dermatology

Published: May 23, 2025

HSR25-181: Assessment of Content Validity of the Functional Assessment of Cancer Therapy - Cutaneous T-Cell Lymphoma (FACT-CTCL).

HSR25-181: Assessment of Content Validity of the Functional Assessment of Cancer Therapy - Cutaneous T-Cell Lymphoma (FACT-CTCL).

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 28, 2025

Showing 1-12 of 46

Last Updated: 09/26/2026